The observed protection against pathologic cardiac hypertrophy and diastolic dysfunction exhibited by the strNrip1–/– mice in response to PWAB led us to explore the impact of cardiac RIP140 deficiency in HF with reduced EF. The gene discussed is NRIP1; the disease is cardiac hypertrophy.